These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7969221)

  • 21. Society of Critical Care Medicine, nineteenth annual educational and scientific symposium. San Francisco, California, May 29-June 1, 1990. Abstracts.
    Crit Care Med; 1990 Apr; 18(4 Suppl):S165-292. PubMed ID: 2311408
    [No Abstract]   [Full Text] [Related]  

  • 22. [Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease].
    Goetz CG
    Rev Neurol (Paris); 2010 Jan; 166(1):1-4. PubMed ID: 19910010
    [No Abstract]   [Full Text] [Related]  

  • 23. The PSG 32nd Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders.
    Mov Disord; 2022 Jun; 37 Suppl 1():S1-S36. PubMed ID: 35647911
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis B: the disease and its prevention. Proceedings of a symposium. October 17, 1988, San Francisco, California, and October 21, 1988, Washington, D.C.
    Am J Med; 1989 Sep; 87(3A):1S-41S. PubMed ID: 2773979
    [No Abstract]   [Full Text] [Related]  

  • 25. Abstracts of the The Movement Disorder Society's 10th International Congress of Parkinson's Disease and Movement Disorders, October 30-November 2, 2006, Kyoto, Japan.
    Mov Disord; 2006; 21 Suppl 15():S329-722. PubMed ID: 16988935
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of hyperkinetic movement disorders.
    Jankovic J
    Lancet Neurol; 2009 Sep; 8(9):844-56. PubMed ID: 19679276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenomenological approach to the correct diagnosis of Parkinson's disease.
    Metzer WS
    J Ark Med Soc; 1992 May; 88(12):607-9. PubMed ID: 1601829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abstracts of the 8th International Symposium on NeuroVirology, 30 October-2 November 2007, San Diego, California, USA.
    J Neurovirol; 2007; 13 Suppl 1(Suppl 1):3-135. PubMed ID: 17987484
    [No Abstract]   [Full Text] [Related]  

  • 29. National conference on Parkinson's disease.
    Rajput AH; Calne D; Lang AE
    Can J Neurol Sci; 1991 Feb; 18(1):87-92. PubMed ID: 1674670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease.
    Chase TN; Engber TM; Mouradian MM
    Adv Neurol; 1996; 69():497-501. PubMed ID: 8615171
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions.
    Jankovic J; Bressman S; Dauer W; Kang UJ
    Mov Disord; 2015 Dec; 30(14):1862-9. PubMed ID: 26477883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep brain stimulation for Parkinson's disease and other movement disorders.
    Kalia SK; Sankar T; Lozano AM
    Curr Opin Neurol; 2013 Aug; 26(4):374-80. PubMed ID: 23817213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurosurgical treatment of Parkinson's disease and other movement disorders. Bibliography.
    Neurochirurgie; 1997; 43 Suppl 1():99-111. PubMed ID: 9289661
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B Today: New Guidelines for the Pediatrician. Proceedings of Symposium at the American Academy of Pediatrics Annual Meeting. San Francisco, California, October 15, 1992.
    Pediatr Infect Dis J; 1993 May; 12(5):425-53. PubMed ID: 8327311
    [No Abstract]   [Full Text] [Related]  

  • 35. Advances in the treatment of Parkinson's disease and other dyskinaesias.
    LEVY LF
    Cent Afr J Med; 1962 Oct; 8():383-8. PubMed ID: 13930277
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease.
    Espay AJ; Lang AE; Chen R
    Mov Disord; 2010 Jan; 25(2):252; author reply 253. PubMed ID: 20063321
    [No Abstract]   [Full Text] [Related]  

  • 37. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.
    Barbeau A
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534982
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of high energy electrons in the treatment of cancer. 25th annual San Francisco Cancer Symposium. San Francisco, California, February 9-11, 1990.
    Front Radiat Ther Oncol; 1991; 25():1-333. PubMed ID: 1874452
    [No Abstract]   [Full Text] [Related]  

  • 39. Parkinson's disease and movement disorders: moving forward.
    Jankovic J
    Lancet Neurol; 2008 Jan; 7(1):9-11. PubMed ID: 18093549
    [No Abstract]   [Full Text] [Related]  

  • 40. XIIth International Symposium on Parkinson's Disease. London, England, March 23-26, 1997. Abstracts.
    Mov Disord; 1997; 12 Suppl 1():1-143. PubMed ID: 9090393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.